Allarity Therapeutics, Inc.
For the period ended Jun 26, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 26, 2026 · Filed Apr 30, 2026
Use the contents to explore the available documents and sections.
Contents
PROXY STATEMENT
PROXY STATEMENT FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS
This 2026 proxy statement (the “Proxy Statement”) includes certain information about Allarity Therapeutics, Inc. (the “Company,” “we,” “us” or “our”) and is being furnished in connection with the solicitation of proxies by our Board of Directors (our “Board”) for use at our 2026 Annual Meeting of Stockholders to be held virtually on Friday, June 26, 2026 at 10:00 a.m., Eastern Time, and at any continuation, postponement or adjournment thereof (the “Annual Meeting”). You should read this Proxy Statement carefully before voting.
For more complete information regarding our 2025 performance, you are encouraged to review our 2025 Annual Report to Stockholders and our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
The Annual Meeting will be conducted exclusively by live webcast. You will be able to attend and participate in the Annual Meeting online, vote your shares electronically and submit your questions during the meeting by visiting https://meetnow.global/MDD2GAD at the meeting date and time described in this Proxy Statement. There is no physical location for the Annual Meeting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.